Awaiting Regulatory Approvals to Launch Covaxin for Children, Says Bharat Biotech After Emergency Use Nod
India’s Central Drug Authority has recommended granting emergency use authorisation to Covaxin for children in the 2 to 18 years age group with certain conditions.